Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Enriched Heparin for Non-Critical COVID-19
NCT04743011Phase 2Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina de Botucatu
- Start
- Jun 2021
- Primary completion
- Nov 2021
- Countries
- 1
01
Overview
A Phase 2 trial of heparin in coronavirus disease 2019 (COVID-19), sponsored by Hospital das Clínicas da Faculdade de Medicina de Botucatu. Started Jun 2021; status: completed.
02
Drugs
heparin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04743011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04743011.